3,4-dihydroxyphenylglycol has been researched along with Parkinsonian Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, DS; Holmes, C; Sharabi, Y | 1 |
| Imanishi, M; Kaneda, K; Kita, H; Nambu, A; Shigemoto, R; Tachibana, Y; Takada, M | 1 |
| Baklaushev, VP; Chekhonin, VP; Dmitrieva, TB; Filatova, TS; Kogan, BM; Lebedev, SV; Man'kovskaya, IV; Savchenko, EA; Yusupova, IU | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylglycol and Parkinsonian Disorders
| Article | Year |
|---|---|
Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Biomarkers; Catecholamines; Dopamine Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Pure Autonomic Failure; ROC Curve | 2012 |
Down-regulation of metabotropic glutamate receptor 1alpha in globus pallidus and substantia nigra of parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Behavior, Animal; Benzoates; Cell Count; Disease Models, Animal; Down-Regulation; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Globus Pallidus; Glycine; Immunohistochemistry; Indans; Macaca fascicularis; Male; Methoxyhydroxyphenylglycol; Parkinsonian Disorders; Receptors, Metabotropic Glutamate; Severity of Illness Index; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |
Catecholamines and their metabolites in the brain and urine of rats with experimental Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Catecholamines; Dihydroxyphenylalanine; Dopamine; Epinephrine; Homovanillic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar | 2000 |